71580 Federal Register / Vol. 88, No. 199 / Tuesday, October 17, 2023 / Notices 

Dated: October 11, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–22842 Filed 10–16–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Rural Health and Economic 

Development Analysis Program 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Announcing funding 

supplement for Rural Health and 

Economic Development Analysis 

Program. 

SUMMARY: HRSA provided additional 

award funds to the Rural Health and 

Economic Development Analysis 

Program recipient to produce a research 

project that quantifies the relationships 

between health care and economic 

factors in rural communities. 

FOR FURTHER INFORMATION CONTACT: 

Karis Tyner, Federal Office of Rural 

Health Policy, HRSA, at ktyner@

hrsa.gov and (240) 645–5756. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: The 

University of Kentucky. 

Amount of Non-Competitive Award: 

One award for $250,000. 

Project Period: September 1, 2023, to 

August 31, 2024. 

CFDA Number: 93.155. 

Award Instrument: Supplement. 

Authority: Social Security Act section 

711(b) (42 U.S.C. 912(b)). 

TABLE 1—RECIPIENT AND AWARD AMOUNT

Grant No. Award recipient name City, state Supplemental 

award amount 

5 U1ZRH33331 ....................... The University of Kentucky ...................................................... Lexington, KY ......................... $250,000 

Justification: This funding will 

provide a one-time supplement to the 

University of Kentucky via the Rural 

Health and Economic Development 

Analysis Program with a budget period 

of September 2023 through August 

2024. This supplement will allow the 

University of Kentucky to build on past 

and ongoing projects supported by 

HRSA to improve health care in rural 

areas by advancing the knowledge base 

regarding the economic impacts of local 

health care sectors on rural economies. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–22814 Filed 10–16–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of Solicitation of 

Written Comments on Healthy People 

2030 Objectives 

AGENCY: Office of Disease Prevention 

and Health Promotion, Office of the 

Assistant Secretary of Health, Office of 

the Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

solicits written comments from the 

public on the current Healthy People 

2030 objectives, and written comments 

from the public proposing additional 

new core, developmental, or research 

objectives or topics to be included in 

Healthy People 2030. Public comment 

informed the development of Healthy 

People 2030. HHS will provide 

opportunities for public input 

periodically throughout the decade to 

ensure Healthy People 2030 reflects 

current public health priorities and 

public input. The updated set of 

Healthy People 2030 objectives and 

topics will be incorporated on https://

health.gov/healthypeople. This updated 

set will reflect further review and 

deliberation by Federal Healthy People 

topic area workgroups, the Federal 

Interagency Workgroup on Healthy 

People 2030, and other Federal subject 

matter experts. 

DATES: Written comments will be 

accepted through 11:59 p.m. ET, 

November 20, 2023. 

ADDRESSES: Written comments should 

be submitted by email to 

HP2030Comment@hhs.gov. 

FOR FURTHER INFORMATION CONTACT: Erik 

Orta, Office of Disease Prevention and 

Health Promotion, U.S. Department of 

Health and Human Services, 1101 

Wootton Parkway, Suite 420, Rockville, 

MD 20852; Phone: 240–268–0823; 

Email: HP2030@hhs.gov. 

SUPPLEMENTARY INFORMATION: Since 

1980, Healthy People has provided a 

comprehensive set of national health 

promotion and disease prevention 

objectives with 10-year targets aimed at 

improving the health of all. Healthy 

People 2030 objectives present a picture 

of the nation’s health at the beginning 

of the decade, establish national goals 

and targets to be achieved by the year 

2030, and monitor progress over time. 

The U.S. Department of Health and 

Human Services (HHS) is soliciting the 

submission of written comments 

regarding the current Healthy People 

2030 objectives. The public is also 

invited to submit proposals for 

additional new core, developmental, or 

research objectives that meet the criteria 

outlined below. 

Healthy People 2030 is the product of 

an extensive collaborative process that 

relies on input from a diverse array of 

individuals and organizations, both 

within and outside the Federal 

Government, with a common interest in 

improving the nation’s health. Public 

comments were a cornerstone of 

Healthy People 2030’s development. 

During the first phase of planning for 

Healthy People 2030, HHS asked for the 

public’s comments on the initiative’s 

vision, mission, and overarching goals. 

Those comments helped set the 

framework for Healthy People 2030. The 

public was also invited to submit 

comments on proposed Healthy People 

2030 objectives, which helped shape the 

current set of Healthy People 2030 

objectives. HHS most recently solicited 

comments on one new objective during 

the 2022 public comment period from 

October 24, 2022, through December 2, 

2022, and three new proposed 

objectives during the 2021 public 

comment period from December 3, 

2021, through January 10, 2022. These 

new objectives, which were developed 

by Healthy People 2030 subject matter 

experts, meet specific criteria, and 

reflect public input, are now accessible 

on https://health.gov/healthypeople. 

While there are no new objectives 

being proposed at this time, the public 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 199 / Tuesday, October 17, 2023 / Notices 71581 

is invited to provide comment on the 

current Healthy People 2030 objectives 

and propose additional core, 

developmental, or research objectives 

for consideration that address critical 

public health issues. Proposed new 

objectives must meet all the objective 

selection criteria (see below). The public 

is also invited to propose new topics to 

be considered for inclusion in Healthy 

People 2030. 

Objective Selection Criteria 

Core Objectives 

Core objectives must meet the 

following five criteria to be included in 

Healthy People 2030. Core objectives 

should (1) have a reliable, nationally 

representative data source with baseline 

data no older than 2015; (2) have at least 

two additional data points beyond the 

baseline during the decade; (3) be of 

national importance; (4) have effective, 

evidence-based interventions available 

to achieve the objective; and (5) have 

data to help address disparities and 

achieve health equity. 

Developmental Objectives 

Developmental objectives will have 

the following characteristics: (1) 

represent high priority issues; (2) do not 

have reliable baseline data yet; and (3) 

have evidence-based interventions 

available. 

Research Objectives 

Research objectives will have the 

following characteristics: (1) represent 

key opportunities to make progress in 

areas with limited prior research, a high 

health or economic burden, or 

significant disparities between 

population groups; (2) may or may not 

have reliable baseline data; and (3) do 

not have evidence-based interventions 

available. 

Written comments and evidencebased information should be submitted 

by email to HP2030Comment@hhs.gov 

by 11:59 p.m. ET on November 20, 2023. 

Comments received in response to this 

notice will be reviewed and considered 

by the Healthy People topic area 

workgroups, Federal Interagency 

Workgroup on Healthy People 2030, and 

other Federal subject matter experts. 

Paul Reed, 

Deputy Assistant Secretary for Health, Office 

of Disease Prevention and Health Promotion. 

[FR Doc. 2023–22805 Filed 10–16–23; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Speech, Language, and Motor 

Function. 

Date: November 8, 2023. 

Time: 10:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sara Louise Hargrave, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3170, 

Bethesda, MD 20892, (301) 443–7193, 

hargravesl@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Biotherapeutics 

Development (CBD). 

Date: November 13–14, 2023. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Laurie Ann Shuman Moss, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 867–5309, laurie.shumanmoss@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Musculoskeletal, Orthopedic, Oral, 

Dermatology and Rheumatology. 

Date: November 15–16, 2023. 

Time: 8:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Aftab A. Ansari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4108, 

MSC 7814, Bethesda, MD 20892, (301) 237– 

9931, ansaria@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–22– 

180: Maximizing Investigators’ Research 

Award (MIRA) (R35-Clinical Trial Optional). 

Date: November 15–16, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Heidi B. Friedman, Ph.D., 

Senior Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 907–H, 

Bethesda, MD 20892, (301) 379–5632, 

hfriedman@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Arthritis, Connective Tissue and 

Skin. 

Date: November 15, 2023. 

Time: 11:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Richard Michael Lovering, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1000J, 

Bethesda, MD 20892, (301) 867–5309, 

loveringrm@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cell and Developmental Biology of 

Eye. 

Date: November 15, 2023. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rass M. Shayiq, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

2359, shayiqr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Drug Development and 

Therapeutics (CDDT). 

Date: November 16–17, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lilia Topol, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0131, ltopol@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Instrumentation, Environmental, 

and Occupational Safety. 


lotter on DSK11XQN23PROD with NOTICES1